Mood disorders Flashcards
MDD prevalence
- Lifetime prevalence is 12%
- 3 times higher for young adults than people over 60
Bipolar prevalence
BP I and II are both around 1% to 1.5%
BP I is equal in men and women
BP II is greater in women
MDD onset
Mean age at 40 years
50% have onset between ages 20 to 50 years
Bipolar age of onset
Can start at 5 years old and all the way to 50+
Mean onset is 30
MDD risk factors
conduct disorder
low education
and other obvious stuff
Bipolar risk factors
Very strong genetic effects
MDD prognosis
Untreated episodes last 6 months to a year
50% will recover in 1st year after hospitalization
5 to 10% will have a manic episode after a while
Bipolar prognosis
50% will have a 2nd manic episode within 2 years.
50 to 60% of patients achieve significant control on lithium
15% suicide rate
Example of a poor prognostic indicator is male gender
Criteria for Dysthymic Disorder (persistent depressive disorder)
2 or more of the MMD symptoms for at least 2 years (1 year for children)
Has never been without symptoms for more than 2 months
Impaired functioning
MADRS
Montgomery-Asberg Depression Rating Scale
EPDS
Edinburgh Postnatal Depression Scale
Adjustment disorder with depressed mood
Psychological symptoms present within 3 months of the stressor
PMDD
depressed prior to menses and end at the start of menses
Mania criteria
Mood change +
Increased goal directed activity or increased energy +
3 or more other symptoms (4 or more if mood is irritable) +
Present for a week
Not due to substances/antidepressants
Hypomania criteria
Same except only lasts 4 days
Mixed episode criteria (mania and depression)
Meets both mania and depressive criteria nearly everyday for a week
MDQ
Mood disorder questionnaire
YMRS
young mania rating scale
BSDS
bipolar spectrum disorder scale
Treatment guidelines for MDD
Medication
Psychotherapy
Possibly medication +psychotherapy
Possible ECT
Treatment guidelines for Severe MDD without psychotic features
Medication
Medication + psychotherapy
ECT
Not psychotherapy alone
Some indicators of severe MDD
PHQ 9 over 20
Duration over 2 years
3 or more episodes
Treatment guidelines for Severe MDD with psychotic features
Medication (antidepressant + antipsychotic)
Medication + psychotherapy
ECT
Not psychotherapy alone
Examples of situations that support the use of psychotherapy
Pregnancy
comorbid personality disorder
Pregnancy and psychotropics
There is limited data
FDA pregnancy risk categories
B - There may or may not be harm in animals, but no evidence of harm in people
C - Harm to animals, but THERE ARE NO studies in humans
D - There is evidence of risk to humans, but occasionally you may still want to use it
X - do not use it
Lactation Risk categories
L2 - limited number of studies without significant risk
L3 - minimal/non-life-threatening risk
L4 - Hazardous, may be used if the mother’s condition is life-threatening
Are you required to notify a patient about off label use?
It’s not legally required, but recommended
Citalopram
Limit to 40 mg (20 mg for people over 60) due to prolonged QT effect
Serotonin syndrome can be associated with giving SSRIs plus
MAOIs
SSRI pregnancy categories
Most are C
Paroxetine is D (cardiac effects)
The baby can have SSRI withdrawal
SSRI lactation category
Sertraline paroxetine are L2
3 pearls about SNRIs
Before starting an SNRI and periodically after starting, measure blood pressure
Avoid them in alcoholism/liver disease due to rare liver toxicity
Contraindicated within 2 weeks of having an MAOI
SNRI pregnancy and lactation categories
C
L3